- CA$161.07m
- CA$136.96m
- 32
- 36
- 48
- 32
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.45 | 1.31 | 0.825 | 8.32 | 12.5 |
Operating Profit | -2.45 | -1.31 | -0.825 | -8.32 | -12.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.22 | -4.61 | -0.829 | -5.67 | -8.22 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.47 | -4.59 | -0.829 | -5.67 | -10.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.47 | -4.59 | -0.829 | -5.67 | -10.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.47 | -4.59 | -0.829 | -5.67 | -10.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.021 | -0.032 | -0.005 | -0.022 | -0.03 |